Lymphatic function is impaired following irradiation of a single lymph node

Lymphatic Research and Biology

Volumn 12, Issue 2, 2014, Pages 76-88

  Baker, Amy ^a   Semple, John L ^b   Moore, Sara ^a   Johnston, Miles ^a  

^a Canada   (Canada)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EVANS BLUE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; DEXTRAN; FLUORESCEIN ISOTHIOCYANATE; FLUORESCENT DYE;

ANIMAL EXPERIMENT; APPLICATION SITE DESQUAMATION; ARTICLE; CONTROLLED STUDY; ERYTHEMA; FEMALE; FLUOROSCOPY; HISTOPATHOLOGY; LYMPH FLOW; LYMPH NODE DISSECTION; LYMPH NODE IRRADIATION; LYMPH VESSEL; MALE; NONHUMAN; POPLITEAL LYMPH NODE; PRIORITY JOURNAL; RADIATION INJURY; RADIATION RESPONSE; SCAR FORMATION; TISSUE WATER; ANALOGS AND DERIVATIVES; ANIMAL; FLOW KINETICS; IMPEDANCE; LYMPH; LYMPH NODE; PHYSIOLOGY; RABBIT; X RAY;

ANIMALS; DEXTRANS; ELECTRIC IMPEDANCE; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; LYMPH; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC VESSELS; MALE; RABBITS; RHEOLOGY; X-RAYS;

EID: 84902458607     PISSN: 15396851     EISSN: 15578585     Source Type: Journal    
DOI: 10.1089/lrb.2013.0036     Document Type: Article

References (57)

1. Meric F Buchholz TA Mirza NQ et al. Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 2002;9:543-549.
2. Ozaslan C Kuru B. Lymphedema after treatment of breast cancer. Am J Surg 2004;187:69-72.
3. Lawenda BD Mondry TE Johnstone PA. Lymphedema: A primer on the identification and management of a chronic condition in oncologic treatment. CA Cancer J Clin 2009; 59:8-24.
4. Armer JM. The problem of post-breast cancer lymphedema: Impact and measurement issues Cancer Invest 2005; 23:76-83.
5. Disipio T Rye S Newman B Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: A systematic review and meta-analysis. Lancet Oncol 2013;14:500-515.
6. Darby S McGale P Correa C et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011;378:1707-1716.
7. Dominick SA Madlensky L Natarajan L Pierce JP. Risk factors associated with breast cancer-related lymphedema in the WHEL Study. J Cancer Surviv 2013;7:115-123.
8. Hayes SC Johansson K Stout N.L Prosnitz R Armer JM Gabram S Schmitz KH. Upper-body morbidity after breast cancer: incidence and evidence for evaluation prevention and management within a prospective surveillance model of care. Cancer 2012;118:2237-2249.
9. McLaughlin SA Wright MJ Morris KT et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: Patient perceptions and precautionary behaviors. J Clin Oncol 2008;26:5220-5226.
10. Park JH Lee WH Chung HS. Incidence and risk factors of breast cancer lymphoedema. J Clin Nurs 2008;17:1450-1459.
11. Spruit PH Siesling S Elferink MA Vonk EJ Hoekstra CJ. Regional radiotherapy versus an axillary lymph node dissection after lumpectomy: A safe alternative for an axillary lymph node dissection in a clinically uninvolved axilla in breast cancer. A case control study with 10 years follow up. Radiat Oncol 2007;2:40.
12. Dale RG. The application of the linear-quadratic doseeffect equation to fractionated and protracted radiotherapy. Br J Radiol 1985;58:515-528.
13. Jones B Dale RG Finst P Khaksar SJ. Biological equivalent dose assessment of the consequences of hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:1379-1384.
14. Baker A Kim H Semple JL Dumont D Shoichet M Tobbia D Johnston M. Experimental assessment of prolymphangiogenic growth factors in the treatment of postsurgical lymphedema following lymphadenectomy. Breast Cancer Res 2010;12:R70.
15. Tobbia D Semple J Baker A Dumont D Johnston M Experimental assessment of autologous lymph node transplantation as treatment of postsurgical lymphedema. Plast Reconstr Surg 2009;124:777-786.
16. Tobbia D Semple J Baker A Dumont D Semple A Johnston M. Lymphedema development and lymphatic function following lymph node excision in sheep. J Vasc Res 2009;46:426-434.
17. Yoffey JM Courtice C. Lymphatics Lymph and the Lymphomyeloid Complex. London: Academic Press; 1970.
18. Jila A Kim H Nguyen VP et al. Lymphangiogenesis following obstruction of large postnodal lymphatics in sheep. Microvasc Res 2007;73:214-223.
19. Kim H Dumont DJ. Molecular mechanisms in lymphangiogenesis: Model systems and implications in human disease. Clin Genet 2003;64:282-292.
20. Das SK Franklin JD O'Brien BM Morrison WA. A practical model of secondary lymphedema in dogs. Plast Reconstr Surg 1981;68:422-428.
21. Engeset A. Irradiation of lymph nodes and vessels. Experiments in rats with reference to cancer therapy. Acta Radiol Diagn (Stockh) 1964:229-221.
22. Avraham T Yan A Zampell JC et al. Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-{beta}1 mediated tissue fibrosis. Am J Physiol Cell Physiol 2010;299: 589-605.
23. Martin M Lefaix JL Pinton P Crechet F Daburon F. Temporal modulation of TGF-beta 1 and beta-actin gene expression in pig skin and muscular fibrosis after ionizing radiation. Radiat Res 1993;134:63-70.
24. Adair TH Guyton AC. Modification of lymph by lymph nodes. II. Effect of increased lymph node venous blood pressure. Am J Physiol 1983;245:H616-622.
25. Adair TH Moffatt DS Paulsen AW Guyton AC. Quantitation of changes in lymph protein concentration during lymph node transit. Am J Physiol 1982;243:H351-359.
26. Adair TH Guyton A. Lymph formation and its modification in the lymphatic system In: Johnston M. G. ed. Experimental Biology of the Lymphatic Circulation. Amsterdam: Elsevier Science Publishers; 1985: pp. 13-44.
27. Aukland K Reed RK. Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiol Rev 1993; 73:1-78.
28. Eisenhoffer J Lee S Johnston MG. Pressure-flow relationships in isolated sheep prenodal lymphatic vessels. Am J Physiol 1994;267:H938-943.
29. Modi S Stanton AW Svensson WE Peters AM Mortimer PS,and Levick JR. Human lymphatic pumping measured in healthy and lymphoedematous arms by lymphatic congestion lymphoscintigraphy. J Physiol 2007;583: 271-285.
30. Thornbury KD McHale NG Allen JM Hughes G. Nervemediated contractions of sheep mesenteric lymph node capsules. J Physiol 1990;422:513-522.
31. Goumans MJ Mummery C. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. Int J Dev Biol 2000;44:253-265.
32. Markwald RR Fitzharris TP Smith WN. Sturctural analysis of endocardial cytodifferentiation. Dev Biol 1975; 42:160-180.
33. Clavin NW Avraham T Fernandez J Daluvoy SV Soares MA Chaudhry A Mehrara BJ. TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair. Am J Physiol Heart Circ Physiol 2008;295:H2113-2127.
34. Jackowski S Janusch M Fiedler E et al. Radiogenic lymphangiogenesis in the skin. Am J Pathol 2007;171:338-348.
35. Nakao S Zandi S Hata Y et al. Blood vessel endothelial VEGFR-2 delays lymphangiogenesis: An endogenous trapping mechanism links lymph-and angiogenesis. Blood 2011;117:1081-1090.
36. Threefoot SA Kent WT Hatchett BF. Lymphaticovenous and lymphaticolymphatic communications demonstrated by plastic corrosion models of rats and by postmortem lymphangiography in man. J Lab Clin Med 1963;61:9-22.
37. Job TT. Lymphaticovenous communications in the common rat and their significance. Am J Anat 1918;24:467.
38. Lee FC. The establishment of collateral circulation following ligation of the thoracic duct. Johns Hopkins Hosp Bull 1922;33:21.
39. Blalock ARC Cunningham RS Gray ME. Experimental studies on lymphatic blockage.Arch Surg 1937;34:1049-1071.
40. Silvester CF. On the presence of permanent vommunications between the lymphatic and the venous system at the level of the renal veins in adult South American monkeys. Am J Anat 1912;12:447.
41. Edwards JM Kinmonth JB. Lymphovenous shunts in man. BMJ 1969;4:579-581.
42. Aboul-Enein A Eshmawy I Arafa S Abboud A. The role of lymphovenous communication in the development of postmastectomy lymphedema. Surgery. 1984;95:562-566.
43. Pain SJ Barber RW Ballinger JR et al. Local vascular access of radioprotein injected subcutaneously in healthy subjects and patients with breast cancer-related lymphedema. J Nucl Med 2004;45:789-796.
44. Pain SJ Barber RW Ballinger JR Solanki CK Mortimer PS Purushotham AD Peters AM. Tissue-to-blood transport of radiolabelled immunoglobulin injected into the web spaces of the hands of normal subjects and patients with breast cancer-related lymphoedema. J Vasc Res 2004;41: 183-192.
45. Pain SJ Barber RW Solanki CK et al. Short-term effects of axillary lymph node clearance surgery on lymphatic physiology of the arm in breast cancer. J Appl Physiol 2005;99:2345-2351.
46. Foldi M. The physiology of the lymphatic vessels. Angiologica 1971;8:212-235.
47. Foldi M. Lymphedema. Krankenpfl J 1983;21:13-18.
48. Hayes S Cornish B Newman B. Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-up. Breast Cancer Res Treat 2005;89:221-226.
49. Hayes S Janda M Cornish B Battistutta D Newman B. Lymphedema secondary to breast cancer: How choice of measure influences diagnosis prevalence and identifiable risk factors. Lymphology 2008;41:18-28.
50. KanterMA Slavin SA Kaplan W. An experimental model for chronic lymphedema. Plast Reconstr Surg 1990;85:573-580.
51. Lee-Donaldson L Witte MH Bernas M Witte CL Way D Stea B. Refinement of a rodent model of peripheral lymphedema. Lymphology 1999;32:111-117.
52. Chvapil M Koopmann CF Jr. Scar formation: Physiology and pathological states. Otolaryngol Clin North Am 1984; 17:265-272.
53. Guyton AC Granger HJ Taylor AE. Interstitial fluid pressure. Physiol Rev 1971;51:527-563.
54. Arriagada R Mouriesse H Rezvani A Sarrazin D Clark RM DeBoer G Bush RS. Radiotherapy alone in breast cancer. Analysis of tumor and lymph node radiation doses and treatment-related complications. The experience of the Gustave-Roussy Institute and the Princess Margaret Hospital. Radiother Oncol 1993;27:1-6.
55. Bates DO. An interstitial hypothesis for breast cancer related lymphoedema. Pathophysiology 2010;17:289-294.
56. Mortimer PS The pathophysiology of lymphedema. Cancer 1998;83:2798-2802.
57. Burnand KM Glass DM Mortimer PS Peters AM. Lymphatic dysfunction in the apparently clinically normal contralateral limbs of patients with unilateral lower limb swelling. Clin Nucl Med 2010;37:9-13.